Please enable JavaScript to continue using this application.

Compare $CYDY vs $LRMR | Chartloom

Compare

$CYDY vs $LRMR

Cytodyn Inc · Larimar Therapeutics Inc

CYDY

Cytodyn Inc

LRMR

Larimar Therapeutics Inc

Compare $CYDY vs $LRMR

Comparing Cytodyn Inc and Larimar Therapeutics Inc

CYDYCytodyn Inc

LRMRLarimar Therapeutics Inc

CYDYCytodyn Inc

Market cap

$274M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-26.0%

52W performance

-24.2%

FCF yield

-6.3%

LRMRLarimar Therapeutics Inc

Market cap

$277M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-23.1%

52W performance

-44.6%

FCF yield

-56.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CYDY

LRMR

Detailed metrics comparison

CYDY

Cytodyn Inc

LRMR

Larimar Therapeutics Inc

Market Cap

CYDY$274M

LRMR$277M

Enterprise Value

CYDY$289M

LRMR$185M

Price

CYDY$0.20

LRMR$2.67

P/E Ratio

CYDYN/A

LRMRN/A

P/S Ratio

CYDY0.00x

LRMR0.00x

EV/Sales

CYDY0.00x

LRMR0.00x

EV/EBITDA

CYDY34.72x

LRMR0.00x

P/B Ratio

CYDY106.18x

LRMR2.41x

P/FCF Ratio

CYDYN/A

LRMRN/A

EV/FCF

CYDY-16.77x

LRMR-1.18x

PEG Ratio

CYDYN/A

LRMRN/A

Forward P/E (NTM)

CYDYN/A

LRMRN/A

Forward P/S (NTM)

CYDYN/A

LRMRN/A

Revenue (TTM)

CYDY$0

LRMR$0

Revenue Growth (YoY)

CYDYN/A

LRMRN/A

Forward Rev Growth

CYDY0.0%

LRMR290.4%

Gross Margin (TTM)

CYDY0.0%

LRMR0.0%

Operating Margin (TTM)

CYDY0.0%

LRMR0.0%

EBITDA Margin (TTM)

CYDY0.0%

LRMR0.0%

Net Margin (TTM)

CYDY0.0%

LRMR0.0%

FCF Margin (TTM)

CYDYN/A

LRMRN/A

Net Income (TTM)

CYDY$-44M

LRMR$-173M

FCF (TTM)

CYDY$-17M

LRMR$-156M

EPS (TTM)

CYDY-$0.03

LRMR-$1.66

ROE (TTM)

CYDY-111387.0%

LRMR-13739.0%

ROA (TTM)

CYDY-31117.0%

LRMR-9765.0%

ROIC (TTM)

CYDY-8873.0%

LRMR-13739.0%

Cash

CYDY$12M

LRMR$93M

Debt

CYDY$27M

LRMR$0

Net Cash/Debt

CYDY$-15M

LRMR$93M

Current Ratio (TTM)

CYDY0.26x

LRMR4.70x

Quick Ratio (TTM)

CYDY0.22x

LRMR4.58x

Debt/Equity (TTM)

CYDY11.55x

LRMR0.00x

Debt/Assets (TTM)

CYDY0.0%

LRMR0.0%

Interest Coverage (TTM)

CYDYN/A

LRMRN/A

Net Debt/EBITDA (TTM)

CYDY0.00x

LRMR0.00x

Beta

CYDY1.76

LRMR0.68

52W Performance

CYDY-24.2%

LRMR-44.6%

YTD Performance

CYDY-26.0%

LRMR-23.1%

% from 52W High

CYDY-49.6%

LRMR-58.4%

% from 52W Low

CYDY9.3%

LRMR2.3%

Asset Turnover (TTM)

CYDY0.00x

LRMR0.00x

FCF Yield (TTM)

CYDY-6.3%

LRMR-56.3%

Earnings Yield (TTM)

CYDY-16.1%

LRMR-62.2%

Dividend Yield (TTM)

CYDYN/A

LRMRN/A

Rule of 40

CYDY0.0

LRMR0.0

EV/GP/RG

CYDYN/A

LRMRN/A

Ticker research

View CYDY research View LRMR research

Metric	CYDY Cytodyn Inc	LRMR Larimar Therapeutics Inc
Market & Valuation
Market Cap	$274M	$277M
Enterprise Value	$289M	$185M
Price	$0.20	$2.67
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	34.72x	0.00x
P/B Ratio	106.18x	2.41x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.77x	-1.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	290.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-44M	$-173M
FCF (TTM)	$-17M	$-156M
EPS (TTM)	-$0.03	-$1.66
ROE (TTM)	-111387.0%	-13739.0%
ROA (TTM)	-31117.0%	-9765.0%
ROIC (TTM)	-8873.0%	-13739.0%
Financial Health
Cash	$12M	$93M
Debt	$27M	$0
Net Cash/Debt	$-15M	$93M
Current Ratio (TTM)	0.26x	4.70x
Quick Ratio (TTM)	0.22x	4.58x
Debt/Equity (TTM)	11.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.76	0.68
52W Performance	-24.2%	-44.6%
YTD Performance	-26.0%	-23.1%
% from 52W High	-49.6%	-58.4%
% from 52W Low	9.3%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-6.3%	-56.3%
Earnings Yield (TTM)	-16.1%	-62.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CYDY research	View LRMR research

Valuation

P/S Ratio

CYDY

0.00x

LRMR

0.00x

EV/FCF

CYDY

-16.77x

LRMR

-1.18x

Growth & revenue

Forward Revenue Growth

LRMR

290.4%

CYDY

0.0%

Profitability & performance

Gross Margin

CYDY

0.0%

LRMR

0.0%

ROE

LRMR

-13739.0%

CYDY

-111387.0%

FCF Yield %

CYDY

-6.3%

LRMR

-56.3%

52-Week Performance

CYDY

-24.2%

LRMR

-44.6%

Detailed metrics comparison

CYDY

Cytodyn Inc

LRMR

Larimar Therapeutics Inc

Market Cap

CYDY$274M

LRMR$277M

Enterprise Value

CYDY$289M

LRMR$185M

Price

CYDY$0.20

LRMR$2.67

P/E Ratio

CYDYN/A

LRMRN/A

P/S Ratio

CYDY0.00x

LRMR0.00x

EV/Sales

CYDY0.00x

LRMR0.00x

EV/EBITDA

CYDY34.72x

LRMR0.00x

P/B Ratio

CYDY106.18x

LRMR2.41x

P/FCF Ratio

CYDYN/A

LRMRN/A

EV/FCF

CYDY-16.77x

LRMR-1.18x

PEG Ratio

CYDYN/A

LRMRN/A

Forward P/E (NTM)

CYDYN/A

LRMRN/A

Forward P/S (NTM)

CYDYN/A

LRMRN/A

Revenue (TTM)

CYDY$0

LRMR$0

Revenue Growth (YoY)

CYDYN/A

LRMRN/A

Forward Rev Growth

CYDY0.0%

LRMR290.4%

Gross Margin (TTM)

CYDY0.0%

LRMR0.0%

Operating Margin (TTM)

CYDY0.0%

LRMR0.0%

EBITDA Margin (TTM)

CYDY0.0%

LRMR0.0%

Net Margin (TTM)

CYDY0.0%

LRMR0.0%

FCF Margin (TTM)

CYDYN/A

LRMRN/A

Net Income (TTM)

CYDY$-44M

LRMR$-173M

FCF (TTM)

CYDY$-17M

LRMR$-156M

EPS (TTM)

CYDY-$0.03

LRMR-$1.66

ROE (TTM)

CYDY-111387.0%

LRMR-13739.0%

ROA (TTM)

CYDY-31117.0%

LRMR-9765.0%

ROIC (TTM)

CYDY-8873.0%

LRMR-13739.0%

Cash

CYDY$12M

LRMR$93M

Debt

CYDY$27M

LRMR$0

Net Cash/Debt

CYDY$-15M

LRMR$93M

Current Ratio (TTM)

CYDY0.26x

LRMR4.70x

Quick Ratio (TTM)

CYDY0.22x

LRMR4.58x

Debt/Equity (TTM)

CYDY11.55x

LRMR0.00x

Debt/Assets (TTM)

CYDY0.0%

LRMR0.0%

Interest Coverage (TTM)

CYDYN/A

LRMRN/A

Net Debt/EBITDA (TTM)

CYDY0.00x

LRMR0.00x

Beta

CYDY1.76

LRMR0.68

52W Performance

CYDY-24.2%

LRMR-44.6%

YTD Performance

CYDY-26.0%

LRMR-23.1%

% from 52W High

CYDY-49.6%

LRMR-58.4%

% from 52W Low

CYDY9.3%

LRMR2.3%

Asset Turnover (TTM)

CYDY0.00x

LRMR0.00x

FCF Yield (TTM)

CYDY-6.3%

LRMR-56.3%

Earnings Yield (TTM)

CYDY-16.1%

LRMR-62.2%

Dividend Yield (TTM)

CYDYN/A

LRMRN/A

Rule of 40

CYDY0.0

LRMR0.0

EV/GP/RG

CYDYN/A

LRMRN/A

Ticker research

View CYDY research View LRMR research

Metric	CYDY Cytodyn Inc	LRMR Larimar Therapeutics Inc
Market & Valuation
Market Cap	$274M	$277M
Enterprise Value	$289M	$185M
Price	$0.20	$2.67
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	34.72x	0.00x
P/B Ratio	106.18x	2.41x
P/FCF Ratio	N/A	N/A
EV/FCF	-16.77x	-1.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	290.4%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-44M	$-173M
FCF (TTM)	$-17M	$-156M
EPS (TTM)	-$0.03	-$1.66
ROE (TTM)	-111387.0%	-13739.0%
ROA (TTM)	-31117.0%	-9765.0%
ROIC (TTM)	-8873.0%	-13739.0%
Financial Health
Cash	$12M	$93M
Debt	$27M	$0
Net Cash/Debt	$-15M	$93M
Current Ratio (TTM)	0.26x	4.70x
Quick Ratio (TTM)	0.22x	4.58x
Debt/Equity (TTM)	11.55x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.76	0.68
52W Performance	-24.2%	-44.6%
YTD Performance	-26.0%	-23.1%
% from 52W High	-49.6%	-58.4%
% from 52W Low	9.3%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	-6.3%	-56.3%
Earnings Yield (TTM)	-16.1%	-62.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CYDY research	View LRMR research